| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Silk Road Medical (NASDAQ:SILK) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Silk Road Medical beat estimated earnings by 21.0%, reporting an EPS of $-0.33 versus an estimate of $-0.42.
Revenue was up $7.20 million from the same period last year.
Last quarter the company beat on EPS by $0.02 which was followed by a 11.0% drop in the share price the next day.
Here's a look at Silk Road Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.35 | -0.39 | -0.39 | -0.38 |
| EPS Actual | -0.33 | -0.35 | -0.43 | -0.34 |
| Revenue Estimate | 44.92M | 43.32M | 40.69M | 37.35M |
| Revenue Actual | 44.44M | 45.30M | 40.13M | 40.07M |
To track all earnings releases for Silk Road Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SILK
